COVID-19 and Subsequent Development of Pancytopenia With Concurrent Disseminated Intravascular Coagulation

Area of Science:

• Hematology
• Infectious Diseases
• Immunology

Background:

• COVID-19 sequelae are known to cause various hematological complications, including lymphopenia, thrombocytopenia, and hypercoagulability.
• While disseminated intravascular coagulation (DIC), immune thrombocytopenic purpura (ITP), and pancytopenia are less common, they can arise following SARS-CoV-2 infection.

Observation:

• The majority of patients developing pancytopenia after COVID-19 have been immunocompromised.
• This report details a rare case of a previously immunocompetent individual who developed severe hematological issues post-COVID-19.

Findings:

• The patient presented with pancytopenia, DIC, and symptoms consistent with ITP approximately one month after a COVID-19 diagnosis.
• This case underscores the potential for severe, multi-lineage hematological complications in immunocompetent individuals following SARS-CoV-2 infection.

Implications:

• This case expands the understanding of potential COVID-19-related hematological sequelae beyond typical presentations.
• Highlights the importance of monitoring for rare but severe blood dyscrasias in immunocompetent patients after COVID-19.
• Suggests a need for further research into the mechanisms underlying these post-infectious hematological complications.